BChE-IN-35

• Description :

  BChE-IN-35 (Azo-9) is a BChE inhibitor. BChE-IN-35 has a dynamic cis/trans conformational change, where the cis isomer preferentially binds to BChE. BChE-IN-35 can be used in Alzheimer's disease (AD) research[1].

• UNSPSC :

  12352005

• Target :

  Cholinesterase (ChE)

• Type :

  Reference compound

• Related Pathways :

  Neuronal Signaling

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/bche-in-35.html

• Smiles :

  CC(C)C1=CC=C(/N=N\C2=CC=C(C(NC3=CC=CC(C(NCC4=CC=CC=C4CN(CC)CC)=O)=C3)=O)C=C2)C=C1

• Molecular Formula :

  C35H39N5O2

• Molecular Weight :

  561.72

• References & Citations :

  [1]Wang L, et al. Optical control of butyrylcholinesterase (BChE) activity via photoswitchable azobenzene for potential treatment of Alzheimer's disease. Bioorg Chem. 2024 Sep 24;153:107845.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  BChE